financetom
Business
financetom
/
Business
/
Generali to return investors more than 8.5 billion euros under new strategy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Generali to return investors more than 8.5 billion euros under new strategy
Jan 29, 2025 10:45 PM

VENICE (Reuters) -Generali on Thursday pledged to return more than 8.5 billion euros ($8.9 billion) to shareholders through dividends and share buybacks through 2027, as CEO Philippe Donnet said he would be ready for a new term.

Donnet, whose term at the helm of Italy's biggest insurer ends in the spring, in the past has come under attack from two billionaire investors who sought in vain to oust him in 2022, complaining he had not done enough for Generali's expansion.

Donnet has the backing of Generali's top investor Mediobanca, a Milanese bank which recently became a takeover target for state-backed Monte dei Paschi (MPS).

Generali said it had earmarked 1.5 billion euros under the plan for mergers and acquisitions, after signing this month a memorandum of understanding with France's BPCE to set up an asset management joint venture that would have more than 1.9 trillion euros in assets.

In presenting its new multi-year strategy, Italy's top insurer committed to growing earnings per share (EPS) by 8-10% a year on average in 2025-2027 with a net cash flow above 11 billion euros, it said in a statement.

The insurer said buybacks would total at least 1.5 billion euros, including 500 million euros for 2025.

($1 = 0.9599 euros)

(Reporting by Gianluca Semeraro; Editing by Valentina Za)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ProMIS Neurosciences Gets Approval to Advance Alzheimer's Disease Treatment to Final Dose Escalation
ProMIS Neurosciences Gets Approval to Advance Alzheimer's Disease Treatment to Final Dose Escalation
Sep 3, 2025
07:46 AM EDT, 09/03/2025 (MT Newswires) -- ProMIS Neurosciences ( PMN ) said Wednesday it received the recommendation of the Data and Safety Monitoring Board to proceed with the third and final dose escalation of its phase 1b trial of PMN310 lead product candidate for the treatment of Alzheimer's disease. The recommendation was based on the review of the available...
Dundee Precious Metals Completes Adriatic Metals Buy, to Change Name and List on ASX
Dundee Precious Metals Completes Adriatic Metals Buy, to Change Name and List on ASX
Sep 3, 2025
07:46 AM EDT, 09/03/2025 (MT Newswires) -- Dundee Precious Metals ( DPMLF ) said Wednesday it has completed its acquisition of all issued and to be issued shares of Adriatic Metals. Adriatic owns the Vares silver-lead-zinc-gold mine in Bosnia and Herzegovina. Dundee said it will change its corporate name to DPM Metals, effective Sept. 12. The company also received conditional...
Peakstone Realty Trust Sells 3 Properties for $177 Million
Peakstone Realty Trust Sells 3 Properties for $177 Million
Sep 3, 2025
07:45 AM EDT, 09/03/2025 (MT Newswires) -- Peakstone Realty Trust ( PKST ) said Wednesday it sold two office properties in Birmingham, Alabama, and Greenwood Village, Colorado, and one industrial property in Sparks Glencoe, Maryland, for about $177 million. The sales were completed in separate deals, the company said. ...
TG Therapeutics Launches New $100 Million Share Buyback Program
TG Therapeutics Launches New $100 Million Share Buyback Program
Sep 3, 2025
07:45 AM EDT, 09/03/2025 (MT Newswires) -- TG Therapeutics ( TGTX ) said Wednesday that its board approved a new share repurchase program of up to $100 million. The new program follows the completion of the previous $100 million share buyback program, which was announced in 2024. Under this program, the company repurchased approximately 3.5 million common shares at an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved